Nurix Therapeutics, Inc. (NRIX)
25.12
-0.69
(-2.67%)
USD |
NASDAQ |
Sep 11, 16:00
25.12
0.00 (0.00%)
After-Hours: 17:34
Nurix Therapeutics Gross Profit (TTM) : 19.51M for May 31, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| May 31, 2026 | 19.51M |
| February 28, 2026 | 53.28M |
| November 30, 2025 | 65.12M |
| August 31, 2025 | 65.16M |
| May 31, 2025 | 70.71M |
| February 28, 2025 | 39.75M |
| November 30, 2024 | 38.12M |
| August 31, 2024 | 40.54M |
| May 31, 2024 | 47.18M |
| February 29, 2024 | 66.52M |
| November 30, 2023 | 63.33M |
| August 31, 2023 | 55.68M |
| May 31, 2023 | 48.50M |
| February 28, 2023 | 29.96M |
| November 30, 2022 | 27.82M |
| Date | Value |
|---|---|
| August 31, 2022 | 30.71M |
| May 31, 2022 | 22.81M |
| February 28, 2022 | 14.01M |
| November 30, 2021 | 6.639M |
| August 31, 2021 | 0.00 |
| May 31, 2021 | 0.00 |
| February 28, 2021 | 0.00 |
| November 30, 2020 | 0.00 |
| August 31, 2020 | 0.00 |
| May 31, 2020 | 0.00 |
| February 29, 2020 | 0.00 |
| November 30, 2019 | 0.00 |
| August 31, 2019 | 0.00 |
| May 31, 2019 | 0.00 |
| February 28, 2019 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Monte Rosa Therapeutics, Inc. | 20.60M |
| Gilead Sciences, Inc. | 24.33B |
| TG Therapeutics, Inc. | 658.60M |
| Cue Biopharma, Inc. | 37.39M |
| Keros Therapeutics, Inc. | 13.41M |